Benedikt von Braunmühl
Rentschler Biopharma
Symposien
In recent years, there have been remarkable success stories from the field of gene and cell therapy, and particularly from CAR-T-therapies. More and more other approaches are being researched or tested in clinical phases, and some have already achieved regulatory approval. Different approaches to cure (rare) diseases and the business models behind it will be presented here.
Prof. Dr. Constanca Figueiredo
Allogenetics
Invisible Organs – a lifelong solution to prevent transplant rejection
Dr. Gerd Maass
Roche Diagnostics
Promises and Challenges of CGT - the Roche Approach